[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Aymes International Limited\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100625044","tolerance-and-acceptability-evaluation-of-an-oral-nutrition-supplement-100625044",false,"NCT07417514","Tolerance and Acceptability Evaluation of an Oral Nutrition Supplement","Tolerance and Acceptability Evaluation of AYMES Protein Shot","Inclusion Criteria:\n\n* Adult patients (≥18 years) who are able to communicate clearly.\n* Diagnosis of renal disease or confirmed requirement for protein supplementation by a suitably qualified health care professional (e.g. dietitian)\n* Participants with or at risk of malnutrition as determined by the SGA nutritional screening tool, MUST and\u002For by professional clinical judgement.\n* Participants expected to require an ONS for at least 28 days from baseline, to take flavour variants orally and neutral via feeding tube.\n* Informed consent obtained.\n\nExclusion Criteria:\n\n* Participation in any other studies involving investigational or marketed products concomitantly or within seven days prior to entry into the study\n* Patients with medical or dietary contraindication to any ingredients (see appendix 2 of protocol for full list.)\n* No feeding tube for any patient taking the neutral variant.\n* Patients with significant hepatic impairment.\n* Patients with dysphagia requiring IDDSI level 1 (or higher) fluids.\n* Patients with uncontrolled inflammatory bowel disease or previous bowel resection with ongoing gastrointestinal symptoms.\n* Any patients having taken antibiotics over the previous 2 weeks leading up to the study.\n* Any participant unable to give consent i.e., those with dementia.\n* Participants under 18 years of age.\n* Individuals who do not have sufficient proficiency with English language\n* Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements.","ALL","18 Years",{"count":19,"type":20},40,"ESTIMATED","INTERVENTIONAL",[23],"NA","To evaluate the tolerance (gastrointestinal) and acceptability of a new Oral Nutrition Supplement in patients with or at risk of disease related malnutrition, taken either orally or via a feeding tube",[26],"Disease Related Malnutrition","RECRUITING","2026-02-11",{"date":30,"type":31},"2026-02-18","ACTUAL",{"date":33,"type":31},"2022-09-30",{"date":35,"type":20},"2026-04",{"name":37,"class":38},"Aymes International Limited","INDUSTRY",""]